Dr. Rizwan E. Kibria, MD

Dr. Kibria practices at Miami Valley Hospital in Dayton, Ohio, part of Premier Health.

Dr. Kibria's NPI, 1730292319, was assigned on August 16, 2006. Dr. Kibria holds Ohio license 35.087650.

Dr. Kibria's primary practice is Miami Valley Hospital, at One Wyoming Street, Dayton, OH 45409 in Montgomery County. The practice phone is (937) 208-3023. Dr. Kibria also practices at Miami Valley Hospital, 1 Wyoming St, Dayton, OH 45409.

Dr. Kibria's primary practice is Miami Valley Hospital in Dayton, Ohio, part of Premier Health. Dr. Kibria is also affiliated with Kettering Health Dayton. The medical group on file is Adena Health System. Dmand AI also links Dr. Kibria to 3 more hospitals, 3 group practices and clinics, 3 medical groups, 1 breast imaging center and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kibria practices, 10 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kibria's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Kibria's licenses on file in 3 states: Ohio, Indiana and Kentucky.

CMS data shows 1,150 Medicare services from Dr. Kibria across 13 procedure codes in 2024, for 540 Medicare patients. Medicare paid $101,081 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 540 Medicare patients who saw Dr. Kibria in 2024. The largest group is 75 to 84, with 205 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kibria's median patient age at 65, with 54% women.

In 2024, Dr. Kibria wrote 35 Medicare Part D claims for 33 patients. 71% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $2,515 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

Dr. Kibria accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 341 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kibria, more than 96% of the clinicians it reports for that procedure.

CMS Open Payments shows 13 general payments to Dr. Kibria from 9 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 72% of the total. Cook Medical LLC paid the most, $1,324.